Global Lung Cancer Therapeutics Industry

10/17/2019 9:21:50 AM

(MENAFN- PR Newswire) NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Lung Cancer Therapeutics market worldwide is projected to grow by US$24 Billion, driven by a compounded growth of 12.9%. Non-Small-Cell Lung Cancer (NSCLC), one of the segments analyzed and sized in this study, displays the potential to grow at over 14%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$28.1 Billion by the year 2025, Non-Small-Cell Lung Cancer (NSCLC) will bring in healthy gains adding significant momentum to global growth.

Read the full report:https://www.reportlinker.com/p05817749/?utm_source=PRN

- Representing the developed world, the United States will maintain a 11.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$948.9 Million to the region's size and clout in the next 5 to 6 years. Over US$771 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Non-Small-Cell Lung Cancer (NSCLC) will reach a market size of US$1.4 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.7% over the next couple of years and add approximately US$5.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. - Competitors identified in this market include among others, Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.Read the full report:https://www.reportlinker.com/p05817749/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Lung Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: Lung Cancer Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 Table 2: Lung Cancer Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 Table 3: Lung Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 Table 4: Non-Small-Cell Lung Cancer (NSCLC) (Type) World Market by Region/Country in US$ Million: 2018 to 2025 Table 5: Non-Small-Cell Lung Cancer (NSCLC) (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 Table 6: Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 Table 7: Small-Cell Lung Cancer (SCLC) (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 Table 8: Small-Cell Lung Cancer (SCLC) (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 Table 9: Small-Cell Lung Cancer (SCLC) (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Lung Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025 Table 10: United States Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 Table 11: Lung Cancer Therapeutics Market in the United States by Type: A Historic Review in US$ Million for 2009-2017 Table 12: United States Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 CANADA Table 13: Canadian Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 Table 14: Canadian Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017 Table 15: Lung Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 JAPAN Table 16: Japanese Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 Table 17: Lung Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 18: Japanese Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 CHINA Table 19: Chinese Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 20: Lung Cancer Therapeutics Historic Market Analysis in China in US$ Million by Type: 2009-2017 Table 21: Chinese Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 EUROPE Market Facts & Figures European Lung Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Table 22: European Lung Cancer Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025 Table 23: Lung Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 Table 24: European Lung Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 Table 25: European Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 26: Lung Cancer Therapeutics Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 27: European Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 FRANCE Table 28: Lung Cancer Therapeutics Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 29: French Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017 Table 30: French Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 GERMANY Table 31: Lung Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 32: German Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 Table 33: German Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 ITALY Table 34: Italian Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 35: Lung Cancer Therapeutics Historic Market Analysis in Italy in US$ Million by Type: 2009-2017 Table 36: Italian Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 UNITED KINGDOM Table 37: United Kingdom Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 Table 38: Lung Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 39: United Kingdom Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 SPAIN Table 40: Spanish Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 Table 41: Spanish Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017 Table 42: Lung Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 RUSSIA Table 43: Russian Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 Table 44: Lung Cancer Therapeutics Market in Russia by Type: A Historic Review in US$ Million for 2009-2017 Table 45: Russian Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 REST OF EUROPE Table 46: Rest of Europe Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 47: Lung Cancer Therapeutics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 48: Rest of Europe Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 ASIA-PACIFIC Table 49: Asia-Pacific Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 Table 50: Lung Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 Table 51: Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 Table 52: Lung Cancer Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 53: Asia-Pacific Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017 Table 54: Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 AUSTRALIA Table 55: Lung Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 56: Australian Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 Table 57: Australian Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 INDIA Table 58: Indian Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 Table 59: Indian Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017 Table 60: Lung Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 SOUTH KOREA Table 61: Lung Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 62: South Korean Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 Table 63: Lung Cancer Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025 REST OF ASIA-PACIFIC Table 64: Rest of Asia-Pacific Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 Table 65: Lung Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 66: Rest of Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 LATIN AMERICA Table 67: Latin American Lung Cancer Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025 Table 68: Lung Cancer Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 Table 69: Latin American Lung Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 Table 70: Latin American Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 71: Lung Cancer Therapeutics Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017 Table 72: Latin American Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 ARGENTINA Table 73: Argentinean Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 74: Lung Cancer Therapeutics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 75: Argentinean Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 BRAZIL Table 76: Lung Cancer Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025 Table 77: Brazilian Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017 Table 78: Brazilian Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 MEXICO Table 79: Lung Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 80: Mexican Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 Table 81: Mexican Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 REST OF LATIN AMERICA Table 82: Rest of Latin America Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 Table 83: Lung Cancer Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017 Table 84: Rest of Latin America Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 MIDDLE EAST Table 85: The Middle East Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 Table 86: Lung Cancer Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017 Table 87: The Middle East Lung Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025 Table 88: The Middle East Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 Table 89: The Middle East Lung Cancer Therapeutics Historic Market by Type in US$ Million: 2009-2017 Table 90: Lung Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 IRAN Table 91: Iranian Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 Table 92: Lung Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 Table 93: Iranian Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 ISRAEL Table 94: Israeli Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 Table 95: Lung Cancer Therapeutics Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017 Table 96: Israeli Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 SAUDI ARABIA Table 97: Saudi Arabian Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 Table 98: Lung Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017 Table 99: Saudi Arabian Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 UNITED ARAB EMIRATES Table 100: Lung Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 101: United Arab Emirates Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 Table 102: Lung Cancer Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025 REST OF MIDDLE EAST Table 103: Lung Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 Table 104: Rest of Middle East Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 Table 105: Rest of Middle East Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 AFRICA Table 106: African Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 Table 107: Lung Cancer Therapeutics Market in Africa by Type: A Historic Review in US$ Million for 2009-2017 Table 108: African Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 IV. COMPETITION BRISTOL-MYERS SQUIBB COMPANY F. HOFFMANN-LA ROCHE AG MERCK & CO., INC. NOVARTIS INTERNATIONAL AG PFIZER, INC V. CURATED RESEARCH Read the full report:https://www.reportlinker.com/p05817749/?utm_source=PRNAboutReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare:S: (339)-368-6001 Intl: +1 339-368-6001

SOURCE Reportlinker